Stockhead TV
Stockhead’s Sarah Hughan sits down with ReNerve (ASX:RNV) CEO Dr Julian Chick to get the short end of the long story on the company’s latest news.
The medical device company specialising in nerve repair has listed on the Australian Securities Exchange after an in-demand $7M capital raising.
Its products are made using proprietary technology, and development is in the final stages.
Tune in to hear ReNerve’s Dr Julian Chick on the IPO details, the company’s packed pipeline, and more.
This video was developed in collaboration with ReNerve, a Stockhead advertiser at the time of publishing.
The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.
Health & Biotech
Long Shortz
Break It Down
